Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
World Journal of Surgery|August 22, 2018
Liver Resection for Solitary Transplantable Hepatocellular Carcinoma: The Role of AFP-ScoreBenjamin Menahem, Christophe Duvoux, Nathalie Ganne, et al.
Radiology|November 18, 2008
Liver cirrhosis: intravoxel incoherent motion MR imaging--pilot studyAlain Luciani, Alexandre Vignaud, Madeleine Cavet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2017
Sofosbuvir-Daclatasvir-Simeprevir Plus Ribavirin in Direct-Acting Antiviral-Experienced Patients With Hepatitis CChristophe Hézode, Slim Fourati, Stéphane Chevaliez, et al.
Gastroenterology|February 5, 2008
Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis CChristophe Hézode, Elie Serge Zafrani, Françoise Roudot-Thoraval, et al.
Nature Medicine|May 23, 2006
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosisFatima Teixeira-Clerc, Boris Julien, Pascale Grenard, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 30, 2011
Transplantation for liver failure in patients with sickle cell disease: challenging but feasibleMonika Hurtova, Dora Bachir, Ketty Lee, et al.
Annals of Surgery|October 6, 2009
Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantationDaniel Cherqui, Alexis Laurent, Nicolas Mocellin, et al.
Hepatology (Baltimore, Md.)|July 3, 2010
Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regenerationFatima Teixeira-Clerc, Marie-Pierre Belot, Sylvie Manin, et al.
Hepatology (Baltimore, Md.)|July 9, 2013
M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver diseaseJinghong Wan, Merieme Benkdane, Fatima Teixeira-Clerc, et al.
Hepatology (Baltimore, Md.)|February 9, 2016
Retreatment with sofosbuvir and simeprevir of patients with hepatitis C virus genotype 1 or 4 who previously failed a daclatasvir-containing regimenChristophe Hézode, Stéphane Chevaliez, Giovanna Scoazec, et al.
Pageof 7